Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support


Disposable Endoscopes Market size was valued at USD 1.7 billion in 2019 and is poised to grow from USD 1.99 billion in 2023 to USD 6.15 billion by 2031, growing at a CAGR of 17% in the forecast period (2024-2031).

To expand their product range and maintain a dominant position in the market, major manufacturers are concentrating on implementing critical business strategies like collaboration, acquisition, and new product releases. Ambu debuted its three brand-new disposable endoscopes in 2021: the gastroscope, duodenoscope, and colonoscope. Zsquare, an Israeli endoscopy company, got US$ 10 million in February 2021 for the creation of a single-use endoscopic platform multiplier. 'Ambu A/S', 'Boston Scientific Corporation', 'CONMED Corporation', 'Cook Medical Incorporated', 'EndoChoice Holdings, Inc.', 'Fujifilm Holdings Corporation', 'Hoya Corporation (Pentax Medical)', 'Johnson & Johnson', 'KARL STORZ GmbH & Co. KG', 'Medtronic plc', 'Olympus Corporation', 'Richard Wolf GmbH', 'Smith & Nephew plc', 'Stryker Corporation', 'Teleflex Incorporated', 'XION GmbH', 'CooperSurgical, Inc. (Wallach Surgical Devices)', 'Micro-Tech Endoscopy', 'Welch Allyn, Inc. (Hill-Rom Holdings, Inc.)', 'Zhejiang Tiansong Medical Instrument Co., Ltd.'

More advancements in this field will be driven by combining and merging various imaging and visualisation techniques like computed tomography and magnetic resonance imaging with endoscopic images, connecting and integrating medical devices in the operating room, and combining endoscopic visualisation with tools, lasers, and other devices and technologies. As a result, during the expected period, technological developments will drive the market for disposable endoscopes to rise.

market expansion is aided by rising consumer demand for low-cost endoscopic operations, an increase in US Food and Drug Administration approvals, and more favourable government rules governing disposable endoscopes. The rise in healthcare spending, increased public awareness of diseases brought on by tainted reusable endoscopes, and an increase in the prevalence of acquired infections linked to medical care are further factors driving the disposable endoscopes market. Medical waste is produced by disposable endoscopes, endangering the environment. Because of this, skilled healthcare professionals no longer favour disposable endoscopes, which inhibits the market's expansion. The market is further constrained by the developing world's low disposable endoscope adoption rates.

With a sales share of more than 41.5% in 2021, North America dominated the market. It is due to the widespread use of cutting-edge technologies, the presence of sophisticated infrastructure, and rising public knowledge of surgeries that require the least amount of incision possible. The regional market is also expected to be driven by the rising incidence of gastrointestinal illnesses, cancer, and the ageing population. Data from the National Cancer Institute show that in 2021, there were around 1,806,590 new cancer cases diagnosed in the United States. In addition, the Centers for Disease Control and Prevention (CDC) reports that approximately 2.4 million Americans saw doctors for digestive system problems.

Feedback From Our Clients

Global Disposable Endoscopes Market

Product ID: SQSG35A2041